TB-500Healing & Recovery

Thymosin Beta-4 fragment studied for recovery and flexibility.

Peptides·Index rating

1/5Speculative

Human data

Safety

Compare prices — from $50.00

Quick factsat a glance

Status: Research / not approved
Developer: Commercial research peptide based on thymosin beta-4 (Tβ4)
Receptors / target: G-actin sequestration (1:1 actin complex regulating cytoskeleton, cell migration, angiogenesis); Tβ4 also reported to engage PINCH/ILK-Akt survival signaling
FDA-approved?: NO
Prescription available?: NO
Studied for: tissue repair & wound healingangiogenesistendon/muscle recoveryactin regulation & cell migration

Overview

"TB-500" is a research peptide sold as related to Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino-acid actin-sequestering peptide involved in cell migration, angiogenesis and wound repair. Analytical work shows commercial "TB-500" typically contains a synthetic fragment of Tβ4 (the N-terminal acetylated 17-23 region), not the full molecule — so it should not be treated as identical to pharmaceutical Tβ4. It is sold research-use-only, has not been evaluated by the FDA, and is prohibited in sport.

Mechanism

Tβ4 is the major monomeric (G-)actin-sequestering peptide in cells, forming a 1:1 complex with actin that regulates cytoskeletal dynamics, cell migration, blood-vessel formation and tissue repair. Preclinical work attributes some reparative and pro-survival effects to a complex with PINCH and integrin-linked kinase (ILK) that activates the Akt survival pathway in cardiac cells. These mechanisms are characterized for Tβ4; the truncated TB-500 fragment is presumed to share actin-binding activity but is far less studied as an intact agent.

Clinical evidence

There are no published human clinical trials of the research chemical "TB-500" itself. The regeneration evidence base for Tβ4 is overwhelmingly animal and in-vitro (e.g., murine cardiac-repair and myocardial-infarction models). The only controlled human trials studied a different, pharmaceutical-grade Tβ4 product — RGN-259, a topical ophthalmic solution — for niche eye conditions; a phase 3 RCT reported improved corneal healing in neurotrophic keratopathy. Those results pertain to a regulated eye drop and do not demonstrate efficacy or safety of injected "TB-500" for muscle, tendon or systemic healing.

Safety profile

Human safety of "TB-500" is essentially unstudied; it is sold as a research compound with no established purity standards or human dosing data, and the only human safety experience is with the unrelated topical Tβ4 product. TB-500/Tβ4 is on the WADA Prohibited List (prohibited at all times, peptide-hormones / growth-factors class) and is detectable in anti-doping testing, so its use is banned in sport. Research use only; no therapeutic or dosing guidance.

Timelinecommonly reported

Weeks 1–4
No controlled human data exists for TB-500. Anecdotal recovery protocols describe effects over weeks; animal Tβ4 healing studies run on similar timescales but do not transfer to humans.
Weeks 4–8
Self-reported plateau in typical anecdotal use; the human time-course is uncharacterized, and TB-500 is prohibited in sport.

Anecdotal reportscommunity-reported

What people describe in forums, blogs and uncontrolled clinic write-ups — experiential and unverified, not clinical evidence and not medical advice.

Tendon, ligament & joint recoverythe most commonly reported use
Recovering from nagging tendon and joint injuries is the dominant reason users report reaching for TB-500, usually alongside BPC-157. A widely-read r/bpc_157 account describes a 3+ year suspected rotator-cuff problem improving markedly after months of self-managed use. Enthusiastic but uncontrolled and unverifiable.
Reddit — r/bpc_157
Reduced pain and better range of motionfrequently reported
The benefit is often framed as day-to-day relief rather than a cure — the same rotator-cuff write-up describes pain with overhead movement and sleeping on the shoulder easing, and range of motion returning over weeks. Self-reported and unverified.
Reddit — r/bpc_157
Used body-wide for several areas at oncecommonly reported
Because TB-500 is described as acting systemically (versus BPC-157's more local action), people often run it to target several problem areas at the same time — one r/bpc_157 log lists tennis elbow, frozen shoulder, bicep tendonitis and shoulder arthritis being addressed together. Whole-body intent, but the effect on any single site can't be isolated.
Reddit — r/bpc_157
Wound and skin-healing anecdotesoccasionally reported
Beyond joints, some users report faster wound and skin healing — a commenter on one r/bpc_157 thread describes second-degree forearm burns healing unusually quickly while running a BPC-157/TB-500 stack. A striking single anecdote, not evidence.
Reddit — r/bpc_157
Typically stacked with BPC-157 for recoveryvery frequently reported
TB-500 is rarely used alone; logs pair it with BPC-157 (and often GHK-Cu, ipamorelin or CJC-1295) as a recovery stack, with the systemic TB-500 seen as complementing BPC-157's more localized effect. Users credit the combination, so TB-500's individual contribution can't be separated.
Reddit — r/bpc_157

Reported side effectsreported in literature

Reported in published literature and user reports. Not a complete list, and not medical advice.

Injection-site reactions
Fatigue or headache (anecdotal)
Limited human safety data

If severe or unexpected symptoms occur, contact a qualified medical professional. PEPTIDES·INDEX does not provide medical advice.

Cautionsdiscuss with a clinician

Use caution or avoid if

No human contraindication data exist for TB-500; the cautions below are theoretical and grounded in preclinical biology, not human findings.
As a pro-angiogenic, pro-migration agent, TB-500 carries a theoretical caution with active malignancy (promoting blood-vessel formation and cell migration could in principle support tumor spread); this concern is animal-derived and has not been demonstrated in humans.
Prohibited in sport at all times; not for human consumption. No safety data exist for use during pregnancy, breastfeeding, or any medical condition.

Interactions

No documented human drug interactionsInteraction profile uncharacterized in humans (research use only)

Compare

vs BPC-157
Frequently paired in anecdotal recovery protocols; also a preclinical repair peptide with no human efficacy trials
vs Wolverine
A blend marketed for recovery/repair that pairs TB-500-type and BPC-157-type peptides

FAQ

Is TB-500 FDA-approved?

No. TB-500 has not been evaluated by the FDA and is sold research-use-only. The only controlled human trials involved a different, pharmaceutical-grade thymosin beta-4 eye drop (RGN-259), not injected TB-500.

Is TB-500 the same as thymosin beta-4?

Not exactly. Analytical work shows commercial TB-500 is typically a synthetic fragment of thymosin beta-4 (the N-terminal acetylated 17-23 region), not the full 43-amino-acid molecule, so it should not be treated as identical to pharmaceutical Tbeta4.

Is TB-500 banned in sport?

Yes. TB-500/thymosin beta-4 is on the WADA Prohibited List (prohibited at all times) and is detectable in anti-doping testing.

How does TB-500 work?

The parent peptide Tbeta4 is the major monomeric (G-)actin-sequestering peptide in cells, forming a 1:1 complex with actin that regulates the cytoskeleton, cell migration, blood-vessel formation and repair; some reparative effects are attributed to a PINCH/ILK-Akt survival pathway. These mechanisms are characterized for full Tbeta4 in preclinical models, and the truncated TB-500 fragment is far less studied as an intact agent.

What route is TB-500 used by?

In anecdotal protocols it is injected subcutaneously or intramuscularly; there is no oral form with evidence behind it. Crucially there are no human trials of injected TB-500, so dose, route and any benefit in people are unestablished.

How does TB-500 compare with BPC-157?

They are frequently paired in anecdotal recovery protocols and are both preclinical repair peptides with no human efficacy trials. A key difference: TB-500/Tbeta4 is explicitly on the WADA Prohibited List and is detectable in testing, so it is a clear anti-doping violation. Both should be treated as research-use-only.

Similar compounds

BPC-157Healing & RecoveryBody-protective compound studied for tissue and gut repair.WolverineBlendBPC-157 + TB-500 recovery stack in a single vial.GHK-CuCosmetic / SkinCopper peptide studied for skin, hair and collagen.

Sources

Starting references for the library summary. These are not dosing instructions or medical advice.

Thymosin beta4: actin-sequestering protein moonlights to repair injured tissuesTrends in Molecular Medicinepubmed.ncbi.nlm.nih.gov/16099219/…Animal studies with thymosin beta, a multifunctional tissue repair and regeneration peptideAnnals of the New York Academy of Sciencespubmed.ncbi.nlm.nih.gov/20536453/…Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repairNaturepubmed.ncbi.nlm.nih.gov/15565145/…Thymosin beta4 is cardioprotective after myocardial infarctionAnnals of the New York Academy of Sciencespubmed.ncbi.nlm.nih.gov/17600280/…RGN-259 (Thymosin beta4) Ophthalmic Solution Promotes Healing in Neurotrophic Keratopathy Patients in a Randomized, Placebo-Controlled, Double-Masked Phase III Clinical TrialInternational Journal of Molecular Sciencespubmed.ncbi.nlm.nih.gov/36613994/…Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potentialDrug Testing and Analysispubmed.ncbi.nlm.nih.gov/22962027/…

For research-use educational context only. Not medical advice and not a recommendation to use any compound. Consult a qualified healthcare professional before any health decision.